|
Dr. Goldenberg founded Immunomedics in July 1982 and has served continuously since that time as the Chairman of our Board of Directors. He also currently serves as our Chief Strategic Officer having been our Chief Scientific Officer from June 2001 to June 2003. Dr. Goldenberg previously served as our Chief Executive Officer from July 1982 through July 1992 from February 1994 through May 1998 and from July 1999 through March 2001. He also serves as Chairman of the Board of Directors of IBC Pharmaceuticals Inc. a subsidiary of Immunomedics. Dr. Goldenberg is a graduate of the University of Chicago College and Division of Biological Sciences (B.S.) the University of Erlangen-Nuremberg (Germany) Faculty of Natural Sciences (Sc.D.) and the University of Heidelberg (Germany) School of Medicine (M.D.). He has written or co-authored more than 1 500 journal articles book chapters and abstracts on cancer research detection and treatment and has researched and written extensively in the area of radioimmunodetection and radioimmunotherapy using radiolabeled antibodies. In addition to his position with Immunomedics Dr. Goldenberg is President of the Center for Molecular Medicine and Immunology (CMMI) an independent non-profit research center and its clinical unit the Garden State Cancer Center. In 1985 and again in 1992 Dr. Goldenberg received an Outstanding Investigator grant award from the National Cancer Institute for his work in radioimmunodetection and in 1986 he received the New Jersey Pride Award in Science and Technology. Dr. Goldenberg was honored as the ninth Herz Lecturer of the Tel Aviv University Faculty of Life Sciences. In addition he received the 1991 Mayneord 3M Award and Lectureship of the British Institute of Radiology and in 2002 the Elis Bervin Lectureship from the Swedish Medical Society and the Swedish Oncology Society for his contributions to the development of radiolabeled monoclonal antibodies used in the imaging and treatment of cancer. The International Society also named Dr. Goldenberg the co-recipient of the 1994 Abbott Award for Oncodevelopmental Biology and Medicine. | 